Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Cancer chemotherapy and

FLUOROPYRIMIDINES Fluoropyrknidines find diverse use in cancer chemotherapy and other dmg appHcations, as well as in fiber-reactive dyes. Table 13 fists physical properties of representative fluoropyrknidines. [Pg.339]

The inhibitors of RNA polymerase, which generates RNA from DNA, inhibit a crucial step in gene expression. Inhibition of the eukaryotic form of RNA polymerase is used in cancer chemotherapy and is also an important experimental tool. For example, actinomy-cin D binds to the guanine residues in DNA and blocks the movement of the eukaryotic RNA polymerase. Specific inhibitors of bacterial RNA polymerase can be used as antibacterial agents. Most of these inhibitors like rifamycin bind to the prokaryotic enzyme. [Pg.1094]

J.S. Lazo. Bleomycin. In Cancer Chemotherapy and Biological Response Modifiers Vol 18, H.M. Pinedo, D.L. Longo, B.A. Chabner (Eds). Elsevier New York,... [Pg.239]

Rauth, A. M. Goldberg, Z. Misra, V. DT-diaphorase possible roles in cancer chemotherapy and carcinogenesis. Oncol. Res. 1997, 9, 339-349. [Pg.263]

TABLE 63-4. Erythropoietin Products and Their Usual Doses for Anemia from Cancer/Chemotherapy and CKD... [Pg.983]

Cancer chemotherapy and the treatment of cancers are analogous to anti-infectives and the treatment of infections. Cancer cells may be sensitive to certain chemotherapy agents, but then with repeated exposure, the cells become resistant to treatment. The resistant cells then grow and multiply. While tumors may be tested for chemotherapy sensitivity, this area is still developing. Today, tumor sensitivity can demonstrate tumor resistance so that needless exposure to an inadequate therapy and its toxicity can be avoided. [Pg.1281]

Chap. 85 - Cancer Chemotherapy and Treatment Universal Program Number 014-999-07-100-H01... [Pg.1712]

Kaye SB. New antimetabolites in cancer chemotherapy and their clinical impact. Br J Cancer 1998 78 1-7. [Pg.514]

The answer is c. (Katzung, pp 608-609, 932-9.13.) Methotrexate is classified as an anti metabolite with therapeutic uses in cancer chemotherapy and as an immunosuppressive agent indicated in the treatment of severe active classical rheumatoid arthritis. Leucovorin is related to methotrexate in that it is an antagonist of its actions. It can supply a source of reduced folate for the methylation reactions that are prevented by methotrexate. [Pg.97]

Cyanide compounds have been prescribed by physicians for treatment of hypertension and cancer (Sprine et al. 1982). Sodium nitroprusside (Na2Fe(CN)5NO 2H20) was widely used for more than 30 years to treat severe hypertension and to minimize bleeding during surgery (Solomon-son 1981 Vesey 1987). Laetrile, an extract of ground apricot kernels, has been used for cancer chemotherapy and, in deliberate high intakes, as an attempted suicide vehicle (Gee 1987). [Pg.918]

The following overview is limited to control of emesis induced by cancer chemotherapy and presents more important developments in the last decade. The reader is referred to more extensive reviews and monographs on this subject [30, 37, 122-126]. [Pg.316]

Chen, S.Z., Jiang, M. and Zhen, Y.S. (2005) HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin. Cancer Chemotherapy and Pharmacology, 56, 212-220. [Pg.78]

Abe S, Tokizaki T, Miki Y, Tateishi A, Ogawa K, Nakano H, Matsushita T (2005) Hyperthermic isolated regional perfusion with CDDP for bone and soft-tissue sarcoma of the lower limb pharmacokinetics, thermal dose, toxicity, and feasibility. Cancer Chemotherapy and Pharmacology 56 55-62. [Pg.257]

Bourgeois H, Vermorken J, Dark G, Jones A, Fumoleau P, Stupp R, Tourani J, Brain E, Nguyen L, Lefresne F, Puozzo C (2007) Evaluation of oral versus intravenous dose of vinorelbine to achieve equivalent blood exposures in patients with solid tumours. Cancer Chemotherapy and Pharmacology 60 407 113. [Pg.258]

Lush RM, Mccune JS, Tetteh L, Thompson JA, Mahany JJ, Garland L, Suttle AB, Sullivan DM (2005) The absolute bioavailability of oral vinorelbine in patients with solid tumors. Cancer Chemotherapy and Pharmacology 56 578-584. [Pg.262]

Horizons for Cancer Chemotherapy (and Nonchemotherapy) Daniel D. Von Hoff 445... [Pg.1]


See other pages where Cancer chemotherapy and is mentioned: [Pg.320]    [Pg.318]    [Pg.985]    [Pg.1277]    [Pg.1279]    [Pg.1281]    [Pg.1283]    [Pg.1285]    [Pg.1287]    [Pg.1289]    [Pg.1291]    [Pg.1293]    [Pg.1295]    [Pg.1297]    [Pg.1299]    [Pg.1301]    [Pg.1686]    [Pg.10]    [Pg.557]    [Pg.96]    [Pg.237]    [Pg.85]    [Pg.4]    [Pg.86]    [Pg.94]    [Pg.163]    [Pg.919]    [Pg.235]    [Pg.298]    [Pg.445]    [Pg.445]    [Pg.447]    [Pg.449]   
See also in sourсe #XX -- [ Pg.136 ]




SEARCH



Cancer Chemotherapy and Biotherapy

Cancer chemotherapy

Cancer treatments and chemotherapies that use metal compounds

Chemical and Biotechnological Developments in Organotin Cancer Chemotherapy

Chronic disease and cancer chemotherapy

Taxol (Paclitaxel) and Cancer Chemotherapy

© 2024 chempedia.info